Cell Lines Used in This Study
Cell Lines Used . | Characteristics . |
---|---|
IM9 | A lymphoblastoid B-cell line that was transformed with EBV |
Vec-TF IM9 | IM9 cells which were stably transfected with empty vector construct |
AS-TF IM9 | IM9 cell lines which were stably transfected with antisense CD99 expression construct |
Mut-IM9 | A spontaneous mutant of IM9 cells which was negative for CD99 expression |
BJAB | A Burkitt’s lymphoma B-cell line that is free of EBV |
AS-TF BJAB | BJAB cells lines which were stably transfected with antisense CD99 expression construct |
HDLM-2 | Established from nodular sclerosis of HD, T lineage |
L428 | Established from nodular sclerosis of HD, probable dendritic cell origin |
KM-H2 | Established from mixed cellularity of HD, B lineage |
Cell Lines Used . | Characteristics . |
---|---|
IM9 | A lymphoblastoid B-cell line that was transformed with EBV |
Vec-TF IM9 | IM9 cells which were stably transfected with empty vector construct |
AS-TF IM9 | IM9 cell lines which were stably transfected with antisense CD99 expression construct |
Mut-IM9 | A spontaneous mutant of IM9 cells which was negative for CD99 expression |
BJAB | A Burkitt’s lymphoma B-cell line that is free of EBV |
AS-TF BJAB | BJAB cells lines which were stably transfected with antisense CD99 expression construct |
HDLM-2 | Established from nodular sclerosis of HD, T lineage |
L428 | Established from nodular sclerosis of HD, probable dendritic cell origin |
KM-H2 | Established from mixed cellularity of HD, B lineage |